If approved, Cinryze would be the first C1 esterase
inhibitor product approved for preventative therapy of HAE across all of Europe.
In a poster entitled, 'Open-Label Use of Nanofiltered C1 Esterase
Inhibitor (Human) (nf-C1 INH for the Prophylaxis of Hereditary Angioedema (HAE) Attacks,' Dr.
About ViroPharma Incorporated ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options, including C1 esterase
inhibitor deficiency, treatment of seizures in children and adolescents, adrenal insufficiency (AI), and C.
Multiple regression analysis was used to investigate a model relating leukocyte esterase
and hemoglobin field reflectance.
activity and populations of soil microorganisms inhabiting cattail (Typha latifolia) and spike rush (Eleocharis tuberculosa) stands growing in a crude oil and brine spill within the Roy E.
NASDAQ: SNTS) and Pharming Group NV (NYSE Euronext: PHARM) today announced that their pivotal Phase III clinical study to evaluate the safety and efficacy of the investigational drug RUCONEST([R]) (recombinant human C1 esterase
inhibitor) 50 U/kg for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema (HAE) met the primary endpoint of time to beginning of symptom relief.
Food and Drug Administration (FDA) has granted 12 years of exclusivity to RUCONEST (C1 esterase
inhibitor recombinant ) 50 IU/kg.
inhibitor[recombinant]) is indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).
HAE is a rare genetic disorder caused by a deficiency of C1 Esterase
Also, for example, while reading plates, if the UA dipstick was reported as leukocyte esterase
and nitrite negative but 2+ bacteria is reported microscopically, the UA will be repeated (sometimes 24 hours later).
A very common treatment for Alzheimer's disease is an acetylcholine esterase
inhibitor such as galantamine (Reminyl), rivastigmine (Exelon) and donepezil (Aricept).
Like proliferating bone marrow cells, bone marrow monocytes show non-specific esterase